These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24090124)

  • 1. Randomized trial of infusion set function: steel versus teflon.
    Patel PJ; Benasi K; Ferrari G; Evans MG; Shanmugham S; Wilson DM; Buckingham BA
    Diabetes Technol Ther; 2014 Jan; 16(1):15-9. PubMed ID: 24090124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comments on Patel et al.'s "Randomized trial of infusion set function: steel versus teflon": early catheter failures may differ according to teflon catheter model.
    Renard E; Boizel R
    Diabetes Technol Ther; 2014 Aug; 16(8):545-6. PubMed ID: 24967507
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of steel and teflon infusion catheters on subcutaneous adipose tissue blood flow and infusion counter pressure in humans.
    Højbjerre L; Skov-Jensen C; Kaastrup P; Pedersen PE; Stallknecht B
    Diabetes Technol Ther; 2009 May; 11(5):301-6. PubMed ID: 19425878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin Pump Infusion Set Failures Associated with Prolonged Hyperglycemia: Frequency and Relationship to Age and Type of Infusion Set During 22,741 Infusion Set Wears.
    Kanapka LG; Lum JW; Beck RW
    Diabetes Technol Ther; 2022 Jun; 24(6):396-402. PubMed ID: 35104166
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical performance of three bolus calculators in subjects with type 1 diabetes mellitus: a head-to-head-to-head comparison.
    Zisser H; Wagner R; Pleus S; Haug C; Jendrike N; Parkin C; Schweitzer M; Freckmann G
    Diabetes Technol Ther; 2010 Dec; 12(12):955-61. PubMed ID: 21128842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.
    Raccah D; Sulmont V; Reznik Y; Guerci B; Renard E; Hanaire H; Jeandidier N; Nicolino M
    Diabetes Care; 2009 Dec; 32(12):2245-50. PubMed ID: 19767384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3.
    Schmid V; Hohberg C; Borchert M; Forst T; Pfützner A
    J Diabetes Sci Technol; 2010 Jul; 4(4):976-82. PubMed ID: 20663464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes.
    Karlin AW; Ly TT; Pyle L; Forlenza GP; Messer L; Wadwa RP; DeSalvo DJ; Payne SL; Hanes S; Clinton P; Maahs DM; Buckingham B
    Diabetes Technol Ther; 2016 Jul; 18(7):429-35. PubMed ID: 27227290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Insulin Infusion Sets in CSII for Longer Than the Recommended Usage Time Leads to a High Risk for Adverse Events: Results From a Prospective Randomized Crossover Study.
    Pfützner A; Sachsenheimer D; Grenningloh M; Heschel M; Walther-Johannesen L; Gharabli R; Klonoff D
    J Diabetes Sci Technol; 2015 Sep; 9(6):1292-8. PubMed ID: 26341262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy.
    Heptulla RA; Allen HF; Gross TM; Reiter EO
    Pediatr Diabetes; 2004 Mar; 5(1):10-5. PubMed ID: 15043684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Important determinants of diabetes control in insulin pump therapy in patients with type 1 diabetes mellitus.
    Deeb A; Abu-Awad S; Abood S; El-Abiary M; Al-Jubeh J; Yousef H; AbdelRahman L; Al Hajeri A; Mustafa H
    Diabetes Technol Ther; 2015 Mar; 17(3):166-70. PubMed ID: 25513744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot trial in pediatrics with the sensor-augmented pump: combining real-time continuous glucose monitoring with the insulin pump.
    Halvorson M; Carpenter S; Kaiserman K; Kaufman FR
    J Pediatr; 2007 Jan; 150(1):103-105.e1. PubMed ID: 17188626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].
    Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F
    Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion.
    Weintrob N; Schechter A; Benzaquen H; Shalitin S; Lilos P; Galatzer A; Phillip M
    Arch Pediatr Adolesc Med; 2004 Jul; 158(7):677-84. PubMed ID: 15237068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system.
    Jones SM; Quarry JL; Caldwell-McMillan M; Mauger DT; Gabbay RA
    Diabetes Technol Ther; 2005 Apr; 7(2):233-40. PubMed ID: 15857224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS).
    New JP; Ajjan R; Pfeiffer AF; Freckmann G
    Diabet Med; 2015 May; 32(5):609-17. PubMed ID: 25661981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Prospective Study of Insulin Infusion Set Use for up to 7 Days: Early Replacement Reasons and Impact on Glycemic Control.
    Waldenmaier D; Zschornack E; Buhr A; Pleus S; Haug C; Freckmann G
    Diabetes Technol Ther; 2020 Oct; 22(10):734-741. PubMed ID: 32167382
    [No Abstract]   [Full Text] [Related]  

  • 18. In Vivo Study of the Inflammatory Tissue Response Surrounding a Novel Extended-Wear Kink-Resistant Insulin Infusion Set Prototype Compared With a Commercial Control Over Two Weeks of Wear Time.
    Kastner JR; Eisler G; Torjman MC; Khalf A; Diaz D; Dinesen AR; Loeum C; Strasma PJ; Joseph JI
    J Diabetes Sci Technol; 2023 Nov; 17(6):1563-1572. PubMed ID: 35533132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Intradermal and Subcutaneous Infusion Set Performance Under 24-Hour Basal and Bolus Conditions.
    McVey E; Keith S; Herr JK; Sutter D; Pettis RJ
    J Diabetes Sci Technol; 2015 Aug; 9(6):1282-91. PubMed ID: 26319228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial.
    Battelino T; Conget I; Olsen B; Schütz-Fuhrmann I; Hommel E; Hoogma R; Schierloh U; Sulli N; Bolinder J;
    Diabetologia; 2012 Dec; 55(12):3155-62. PubMed ID: 22965294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.